Michael Medici
Managing Director · Summit Partners
Managing DirectorBoston
Michael Medici is a Managing Director at Summit Partners in Boston, which he joined in 2005 as an Associate, focusing on the technology sector. His current board and investment experience includes Fundraise Up, Klaviyo, MacStadium, Runpod and Vestmark. He previously worked for Prudential Capital Group.
Board seats
77 current
· PUBLIC SOURCES
Credited hits
11
· PUBLIC SOURCES
Midas years
LAST CHECKED NOV 2026
Founder rating
LAST CHECKED NOV 2026
Maintained from public sources. Not claimed. If you're Michael Medici, you can claim this profile.
Claim this profileHow claiming worksClaiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.
Track record
- Acacia Communicationsacquired
Prior investments/directorships on his Summit bio page, annotated NASDAQ: ACIA, later acquired by Cisco
Source: summitpartners.com
- Anesthetixacquired
Acquired by TeamHealth, per Summit Partners team bio.
Source: summitpartners.com
- Clarabridgeacquired
Acquired by Qualtrics, per Summit Partners team bio.
Source: summitpartners.com
- Diagnostic Hybridsacquired
Acquired by Quidel Corporation, per Summit Partners team bio.
Source: summitpartners.com
- Fermentas Internationalacquired
Acquired by Thermo Fisher Scientific, per Summit Partners team bio.
Source: summitpartners.com
- Hiperosacquired
Acquired by Opus Global, per Summit Partners team bio.
Source: summitpartners.com
- Logi Analyticsacquired
Acquired by Marlin Equity Partners, per Summit Partners team bio.
Source: summitpartners.com
- Mi9 Retailacquired
Acquired by General Atlantic, per Summit Partners team bio.
Source: summitpartners.com
- NetBrain Technologiesacquired
Acquired by Blackstone, per Summit Partners team bio.
Source: summitpartners.com
- Telerikacquired
Acquired by Progress Software, per Summit Partners team bio.
Source: summitpartners.com
- Zenossacquired
Acquired by Virtana, per Summit Partners team bio.
Source: summitpartners.com
Board seats
Current board seats · 7
- Fundraise UpSource: summitpartners.com
- KlaviyoSource: summitpartners.com
- LaterSource: summitpartners.com
- MacStadiumSource: summitpartners.com
- RunpodSource: summitpartners.com
- SiftedSource: summitpartners.com
- VestmarkSource: summitpartners.com
Success signals
Forbes Midas List
No public record
Not listed.
Reputation
No reputation score — basis not established for this investor.
No reputation sources on file yet.
Suggest a sourceContact
Published sources only
Published contact details collected from public sources. Not a referral, and not an introduction.
Published contact
- Website
- www.summitpartners.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
Claimed profiles can replace or remove contact details.
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Michael Medici. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewFirm-level reviews are not attributed to Michael Medici.
Methodology
This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.
Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.
Corrections with a source: Suggest a correction.
Source record 1
- [1]
DATABASE · GlassVC catalog — Catalog record for Michael Medici — provenance: GlassVC catalog
↩ cites: Title · Firm · Type · Bio · Location · Focus · Credited deals · Board seats
EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026
